Anatomical and clinical predictors of acute bowel toxicity in whole pelvis irradiation for prostate cancer with Tomotherapy

Radiotherapy and Oncology

Volumn 101, Issue 3, 2011, Pages 460-464

  Longobardi, Barbara ^a   Berardi, Genoveffa ^a   Fiorino, Claudio ^a,b   Alongi, Filippo ^a   Cozzarini, Cesare ^a   Deli, Aniko ^a   La MacChia, Mariangela ^a   Perna, Lucia ^a   Di Muzio, Nadia Gisella ^a   Calandrino, Riccardo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

Author keywords

Bowel toxicity; IGRT; Prostate cancer; Tomotherapy

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER RADIOTHERAPY; DISEASE SEVERITY; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PELVIS; PELVIS LYMPH NODE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RECTUM; RECTUM DISEASE; SALVAGE THERAPY; TOMOTHERAPY; TREATMENT DURATION;

AGED; HUMANS; INTESTINES; LOGISTIC MODELS; MALE; PELVIS; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, IMAGE-GUIDED;

EID: 81855165038     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.07.014     Document Type: Article

References (39)

1. C. Cozzarini, C. Fiorino, and N. Di Muzio Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer Radiother Oncol 84 2007 164 170
2. S. Arcangeli, B. Saracino, and M.G. Petrongari Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous Radiother Oncol 84 2007 148 155
3. L.P. Muren, E. Wasbo, and S.I. Helle Intensity-modulated radiotherapy of pelvic lymph nodes in locally advanced prostate cancer: planning procedures and early experiences Int J Radiat Oncol Biol Phys 71 2008 1034 1041
4. J.B. Ashman, M.J. Zelefsky, and M.S. Hunt Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy Int J Radiat Oncol Biol Phys 63 2005 765 771
5. E.J. Adams, D.J. Convery, and V.P. Cosgrove Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph nodes involvement Radiother Oncol 70 2004 1 10
6. G. Sanguineti, E.J. Endres, and B.C. Parker Acute toxicity of whole-pelvis IMRT in 87 patients with localized prostate cancer Acta Oncol 47 2008 301 310
7. C.M. Nutting, D.J. Convery, and V.P. Cosgrove Reduction of small and large bowel irradiation using an optimized intensity-modulated pelvic radiotherapy technique in patients with prostate cancer Int J Radiat Oncol Biol Phys 48 2000 649 656
8. E.A. Miles, C.H. Clark, and M.T.G. Urbano The impact of introducing intensity modulated radiotherapy into clinical practice Radiother Oncol 77 2005 241 246
9. G. Sanguineti, M.L. Cavey, and E.J. Endres Does treatment of the pelvic nodes with IMRT increase late rectal toxicity over conformal prostate-only radiotherapy to 76Gy? Strahlenther Onkol 182 2006 543 549
10. G. Sanguineti, M.L. Cavey, and E.J. Endres Is IMRT needed to spare the rectum when pelvic lymph nodes are part of the initial treatment volume for prostate cancer? Int J Radiat Oncol Biol Phys 64 2006 151 160
11. M. Roach, M. DeSilvio, and C. Lawton Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413 J Clin Oncol 21 2003 1904 1911
12. M.T. Spiotto, S.L. Hancock, and C.R. King Radiotherapy after prostatectomy: improved biochemical relapse-free survival with whole pelvic compared with prostate bed only for high-risk patients Int J Radiat Oncol Biol Phys 69 2007 54 61
13. C. Fiorino, F. Alongi, and S. Broggi Physics aspects of prostate Tomotherapy: planning optimization and image-guidance issues Acta Oncol 47 2008 1309 1316
14. N. Di Muzio, C. Fiorino, and C. Cozzarini Phase I-II study of hypofractionated simultaneous integrated boost with Tomotherapy for prostate cancer Int J Radiat Oncol Biol Phys 74 2009 392 398
15. F. Alongi, C. Fiorino, and C. Cozzarini IMRT significantly reduces acute toxicity of whole-pelvis irradiation in patients treated with post-operative adjuvant or salvage radiotherapy after radical prostatectomy Radiother Oncol 93 2009 207 212
16. C. Fiorino, F. Alongi, and L. Perna Dose-volume relationships for acute bowel toxicity for patients treated with pelvic nodal irradiation for prostate cancer Int J Radiat Oncol Biol Phys 75 2009 29 35
17. L. Perna, F. Alongi, and C. Fiorino Predictors of acute bowel toxicity in patients treated with IMRT whole pelvis irradiation after prostatectomy Radiother Oncol 97 2010 71 75
18. C.A. Lawton, J. Michalski, and I. El-Naqa RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer Int J Radiat Oncol Biol Phys 74 2009 383 387
19. R. Martinez-Monge, P.S. Fernandes, N. Gupta, and R. Gahbauer Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning Radiology 211 1999 815 828
20. G. Sanguineti, M. Little, and E.J. Endres Comparison of three strategies to delineate the bowel for whole pelvis IMRT of prostate cancer Radiother Oncol 88 2008 95 101
21. C. Fiorino, N. Di Muzio, and S. Broggi Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical Tomotherapy Int J Radiat Oncol Biol Phys 71 2008 611 617
22. C. Fiorino, R. Valdagni, T. Rancati, and G. Sanguineti Dose-volume effects for normal tissues in external radiotherapy: pelvis Radiother Oncol 93 2009 153 167
23. J.C. Roeske, D. Bonta, and L.K. Mell A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy Radiother Oncol 69 2003 201 207
24. Cancer Therapy Evaluation Program: Common Toxicity Criteria, version 2.0. http://ctep.cancer.gov/Forms/CTCv20-4-30-992.pdf.
25. Al.B. Benson III, A. Ajani Jaffer, and B. Catalano Robert Recommended guidelines for the treatment of cancer treatment-induced diarrhea J Clin Oncol 22 2004
26. J. Kountouras, and C. Zavos Recent advances in the management of radiation colitis World J Gastroenterol 14 2008 7289 7301
27. J.G. Letschert, J.V. Lebesque, and R.W. de Boer Dose-volume correlation in radiation-related late smallbowel complications: a clinical study Radiother Oncol 18 1990 307 320
28. R.J. Caspers, and W.C. Hop Irradiation of true pelvis for bladder and prostatic carcinoma in supine, prone or Trendelenburg position Int J Radiat Oncol Biol Phys 9 1983 589 593
29. T.G. Shanahan, M.P. Mehta, and K.L. Bertelrud Minimization of small bowel volume within treatment fields utilizing customized "belly boards" Int J Radiat Oncol Biol Phys 19 1990 469 476
30. N. Green The avoidance of small intestine injury in gynecologic cancer Int J Radiat Oncol Biol Phys 9 1983 1385 1390
31. J.F. Rodier, J.C. Janser, and D. Rodier Prevention of radiation enteritis by an absorbable polyglycolic acid mesh sling. A 60-case multicentric study Cancer 68 1991 2545 2549
32. D.M. Brizel, T.H. Wasserman, and M. Henke Phase III randomized trial of amifostine as a radioprotector in head and neck cancer J Clin Oncol 18 2000 3339 3345
33. U. Mutlu-Turkoglu, Y. Erbil, and S. Oztezcan The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats Life Sci 66 2000 1905 1913
34. W.F. Stenson Prostaglandins and epithelial response to injury Curr Opin Gastroenterol 23 2007 107 110
35. S. Torres, L. Thim, and F. Milliat Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat Int J Radiat Oncol Biol Phys 69 2007 1563 1571
36. S. Demirer, S. Aydintug, and B. Aslim S. Effects of probiotics on radiation induced intestinal injury in rats Nutrition 22 2006 179 186
37. G. Fellin, C. Fiorino, and T. Rancati Clinical and dosimetric predictors of late rectal toxicity after conformal radiation for localized prostate cancer: results of a large multicentric observational study Radiother Oncol 93 2009 197 202
38. R. Valdagni, T. Rancati, and M. Ghilotti To bleed or not to bleed. A prediction based on individual gene profiling combined with dose-volume histogram shapes in prostate cancer patients undergoing three-dimensional conformal radiation therapy Int J Radiat Oncol Biol Phys 74 2009 1431 1440
39. V. Fonteyne, W. De Neve, and G. Villeirs Late radiotherapy-induced lower intestinal toxicity (RILIT) of intensity-modulated radiotherapy for prostate cancer: The need for adapting toxicity scales and the appearance of the sigmoid colon as co-responsible organ for lower intestinal toxicity Radiother Oncol 84 2007 156 163